TerminatedNCT02863380

Personalized rTMS for Resistant Depression

Device studyAges 18–65France

The study in practice

Understand this study

Listed age limits: 18 years to 65 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: May 4, 2016

Recruitment status: Terminated
Enrollment listed in the registry: 27
Sponsor: University Hospital, Strasbourg, France
Sponsor type: Hospital / academic medical center
Study type: Device
Intervention type: DEVICE, PROCEDURE
Study phase: Not clearly listed
Locations: France
Age range: From 18 Years to 65 Years
Official registry ID: NCT02863380
Official title: Show the full official title
Validation of Personalized Antidepressant Treatment by Neuromodulation - Pilot Study

Terminated

Strasbourg

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is University Hospital, Strasbourg, France, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.